Relay Therapeutics' GAAP loss for 9M 2021 was $296.416 million, up 3.4 times from $87.688 million in the prior year. Revenue was $2,462 million. The company did not generate revenue a year earlier.
Relay Therapeutics' GAAP loss for 9M 2021 was $296.416 million, up 3.4 times from $87.688 million in the prior year. Revenue was $2,462 million. The company did not generate revenue a year earlier. 
ir.relaytx.com
English (US) 